細胞清洗機市場 - 副產品（設備 [自動、手動]、消耗品 [一次性、可重複使用]）、最終用途（診斷實驗室、血庫、輸血中心） - 全球預測 (2024 - 2032)

Cell Washers Market - By Product (Equipment [Automated, Manual], Consumables [Single-use, Reusable]), End-use (Diagnostic Labs, Blood Banks, Transfusion Centers) - Global Forecast (2024 - 2032)

出版日期: 2024年05月07日 | 出版商:

Global Market Insights Inc. | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在慢性病盛行率上升的推動下，細胞清洗機市場規模在 2024 年至 2032 年期間將呈現 4.8% 的複合年成長率。據世界衛生組織稱，每年，癌症、糖尿病和心血管疾病等非傳染性疾病總共導致全球約 3,600 萬人死亡。細胞清洗機透過確保疾病診斷、藥物開發和個人化治療方法中使用的細胞樣本的純度和活力，在生物醫學研究和臨床診斷中發揮著至關重要的作用。醫療保健提供者越來越強調需要精確、高效的細胞清洗技術，以加強疾病管理並提高患者的治療效果，從而塑造市場前景。

在人們日益重視預防性和個人化醫療保健的推動下，配備最先進生物醫學技術的新醫院、診所和研究中心的建立，將進一步增加未來幾年的產品需求。

細胞清洗機產業根據產品、最終用途和地區進行分類。

到 2032 年，自動化細胞清洗設備領域將快速成長，因為這些先進的系統提高了工作流程效率並確保結果一致。自動化細胞清洗機不僅可以減少人工錯誤，還可以最佳化實驗室和臨床環境中的時間和資源利用率。這項技術飛躍強調了對提高營運效率和維持高標準的研究完整性的承諾，有利於更廣泛的產品採用。

到 2032 年，血庫領域將變得更加突出，因為這些設施依靠細胞清洗機來確保輸血和治療中使用的血液成分的純度和活力。血液製品嚴格的監管標準需要可靠的細胞清洗系統，以有效去除污染物並確保產品安全。隨著血庫擴大產能以滿足不斷成長的醫療保健需求，先進細胞清洗機的採用預計將大幅增加。

在強大的醫療基礎設施和廣泛的研究活動的推動下，到 2032 年，歐洲細胞清洗機產業規模將快速成長。德國、法國和英國等國家正在生物技術和醫療保健領域進行大量投資，從而刺激了對創新細胞清洗解決方案的需求。該地區積極主動的醫療現代化和卓越研究繼續為市場參與者創造利潤豐厚的機會。此外，嚴格的監管框架確保歐洲醫療機構部署的細胞清洗機的高品質和可靠性，進一步促進產業成長。

產業生態系統分析
產業影響力
- 成長動力
  - 慢性病負擔日益加重
  - 輸血需求增加
  - 細胞清洗技術的進步
- 產業陷阱與挑戰
  - 設備成本高
  - 低度開發國家的醫療保健設施有限
成長潛力分析
技術景觀
監管環境
2023 年定價分析
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
裝置
- 自動化
- 手動的
耗材
- 一次使用
- 可重複使用的

第 6 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
診斷實驗室
血庫和輸血中心
其他最終用戶

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Andreas Hettich GmbH & Co. KG
Bio-Rad Laboratories, Inc.
Centurion Scientific
Changsha Yingtai Instrument Co., Ltd.
Corning Incorporated
CYTENA GmbH
Danaher Corporation
Fresenius SE & Co. KGaA
Haemonetics Corporation
Helmer Scientific Inc.
Labtron Equipment Ltd.
LivaNova PLC
Labozon Scientific Inc.
Medfuture Biotech Co., Ltd.
Terumo Corporation

簡介目錄

Product Code: 9399

The Cell Washers Market size will exhibit a 4.8% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases. According to the WHO, every year, non-communicable diseases such as cancer, diabetes, and cardiovascular ailments collectively contribute to an estimated 36 million deaths globally. Cell washers play a crucial role in biomedical research and clinical diagnostics by ensuring the purity and viability of cellular samples used in disease diagnosis, drug development, and personalized treatment approaches. Healthcare providers are increasingly emphasizing the need for precise and efficient cell washing technologies to bolster disease management and elevate patient outcomes, shaping the market outlook.

The establishment of new hospitals, clinics, and research centers equipped with state-of-the-art biomedical technologies, driven by the growing emphasis on preventive and personalized healthcare, will further augment the product demand in the coming years.

The cell washers industry is classified based on product, end-use, and region.

The automated cell washers equipment segment will grow rapidly through 2032, as these advanced systems enhance workflow efficiency and ensure consistent results. Automated cell washers not only reduce manual errors but also optimize time and resource utilization in laboratories and clinical settings. This technological leap underscores the commitment to enhancing operational efficiencies and maintaining high standards of research integrity, favoring wider product adoption.

The blood banks segment will gain prominence through 2032, as these facilities rely on cell washers to ensure the purity and viability of blood components used in transfusions and therapies. The stringent regulatory standards governing blood products necessitate reliable cell washing systems that can effectively remove contaminants and ensure product safety. As blood banks expand their capacities to meet growing healthcare demands, the adoption of advanced cell washers is poised to increase significantly.

Europe cell washers industry size will grow at a fast pace through 2032, driven by robust healthcare infrastructure and extensive research activities. Countries such as Germany, France, and the UK are witnessing substantial investments in biotechnology and healthcare, thereby fueling the demand for innovative cell washing solutions. The region's proactive approach to healthcare modernization and research excellence continues to create lucrative opportunities for market players. Additionally, stringent regulatory frameworks ensure the high quality and reliability of cell washers deployed across European healthcare facilities, further bolstering industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing burden of chronic diseases
  - 3.2.1.2 Rising demand for blood transfusion
  - 3.2.1.3 Advancements in cell washer technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of equipment
  - 3.2.2.2 Limited access to healthcare facilities in underdeveloped countries
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn, Units)

5.1 Key trends
5.2 Equipment
- 5.2.1 Automated
- 5.2.2 Manual
5.3 Consumables
- 5.3.1 Single-use
- 5.3.2 Reusable

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Diagnostic laboratories
6.3 Blood banks and transfusion centers
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn, Units)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa